Lability of monofunctionalcis-platinum adducts: role of DNA double helix
Open Access
- 25 September 1992
- journal article
- research article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 20 (18) , 4825-4830
- https://doi.org/10.1093/nar/20.18.4825
Abstract
Recently, we have shown that the adduct formed in the reaction between the platinum-triamine complex cis-[Pt(NH3)2(N7-N-methyl-2diazapyrenium)CI]2+ and one single-stranded oligonucleotide was stable but became labile as soon as the platinated oligonucleotide was paired with its complementary strand (Gaucheron et al. Proc. Natl. Acad. Sci. USA 88,3516–3519(1991)). To generalize this finding we have now studied large DNA fragments containing several adducts. The stability of the adducts within single-stranded DNA is demonstrated by absorption spectrophotometry and by replication mapping experiments. Several approaches are used to prove the lability of the adducts within double-stranded DNA. Replication mapping experiments reveal that an unmodified single-stranded DNA when mixed with double-stranded DNA modified by the platinum-triamine complex behaves as a singlestranded DNA modified by the triamine complex. After double-stranded DNA is modified by the platinum triamine complex, intrastrand and interstrand crosslinks are progressively formed during subsequent incubation as revealed by transcription mapping experiments and gel electrophoresis under denaturing conditions. Finally, replication mapping experiments show that the lability of the adducts within a doublestranded DNA depends upon the nature of the flanking nucleotide residues. All these results support the proposal that the DNA double helix acts as a catalyst in the reaction between DNA, cis-diamminedichioroplatinum(II) and N-methyl-2,7-diazapyrenium.Keywords
This publication has 16 references indexed in Scilit:
- Replication inhibition and translesion synthesis on templates containing site- specifically placed cis-diamminedichloroplatinum(II) DNA adductsBiochemistry, 1992
- Possible catalytic activity of DNA in the reaction between the antitumor drug cis-diamminedichloroplatinum(II) and the intercalator N-methyl-2,7-diazapyrenium.Proceedings of the National Academy of Sciences, 1991
- Interstrand cross-links are preferentially formed at the d(GC) sites in the reaction between cis-diamminedichloroplatinum (II) and DNA.Proceedings of the National Academy of Sciences, 1991
- Transcription by eukaryotic and prokaryotic RNA polymerases of DNA modified at a d(GG) or a d(AG) site by the antitumor drug cis-diamminedichloroplatinum(II)Biochemistry, 1991
- Identification and characterization of a novel linkage isomerization in the reaction of trans-diamminedichloroplatinum(II) with 5'-d(TCTACGCGTTCT)Biochemistry, 1990
- Chemical and biological properties of a new series of cis-diammineplatinum(II) antitumor agents containing three nitrogen donors: cis-[Pt(NH3)2(N-donor) Cl]+Journal of Medicinal Chemistry, 1989
- Reaction of nucleic acids and cis-diamminedichloroplatinum(II) in the presence of intercalating agents.Proceedings of the National Academy of Sciences, 1986
- Sequence-dependent termination of in vitro DNA synthesis by cis- and trans-diamminedichloroplatinum (II).Proceedings of the National Academy of Sciences, 1985
- Alteration and activation of sequence-specific cleavage of DNA by bleomycin in the presence of the antitumor drug cis-diamminedichloroplatinum(II).Proceedings of the National Academy of Sciences, 1983
- Ethidium bromide changes the nuclease-sensitive DNA binding sites of the antitumor drug cis-diamminedichloroplatinum(II).Proceedings of the National Academy of Sciences, 1982